CervoMed
CRVO
14 hedge funds and large institutions have $2.32M invested in CervoMed in 2019 Q2 according to their latest regulatory filings, with 7 funds opening new positions, 0 increasing their positions, 2 reducing their positions, and 2 closing their positions.
250% more first-time investments, than exits
New positions opened: 7 | Existing positions closed: 2
200% more capital invested
Capital invested by funds: $774K → $2.32M (+$1.55M)
56% more funds holding
Funds holding: 9 → 14 (+5)
0.24% more ownership
Funds ownership: 0.08% → 0.32% (+0.24%)
100% less repeat investments, than reductions
Existing positions increased: 0 | Existing positions reduced: 2
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
SM
Sabby Management
Miami Beach,
Florida
|
+$1.68M |
| 2 |
AFM
Anson Funds Management
Dallas,
Texas
|
+$1.18M |
| 3 |
Wells Fargo
San Francisco,
California
|
+$539K |
| 4 |
Acadian Asset Management
Boston,
Massachusetts
|
+$61.2K |
| 5 |
VF
Virtu Financial
New York
|
+$42.6K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BCM
Bridgeway Capital Management
Houston,
Texas
|
-$78K |
| 2 |
Vanguard Group
Malvern,
Pennsylvania
|
-$35K |
| 3 |
Renaissance Technologies
New York
|
-$27.2K |
| 4 |
UBS Group
Zurich,
Switzerland
|
-$13K |
CRVO Hedge Fund Activity: Q2 2019 in Review
14 of the 4,604 institutional investors tracked by Wall St. Rank reported a position in CervoMed (CRVO) for Q2 2019, worth a combined $2.32M — up 200% from $774K a quarter earlier.
Buyers outnumbered sellers: 7 funds opened new CRVO positions and 2 closed out — a net gain of 5 holders — while 0 added to existing stakes and 2 trimmed.
The largest buyer was Sabby Management, opening a new position worth an estimated $1.68M. The largest seller was Bridgeway Capital Management, exiting entirely with an estimated $78K sold.
- 14 institutional investors held CervoMed (CRVO) as of Q2 2019, up from 9 in Q1 2019.
- Funds reported $2.32M of CervoMed stock for Q2 2019, up 200% quarter-over-quarter.
- 7 funds opened new CervoMed positions in Q2 2019 and 2 closed out, a net change of +5 holders.
- The largest CervoMed buyer in Q2 2019 was Sabby Management, an estimated $1.68M added.
- The largest CervoMed seller in Q2 2019 was Bridgeway Capital Management, an estimated $78K sold.
Based on aggregated 13F filings for Q2 2019.